Explora cada aspecto de la vida con enfermedad renal
A systematic review comparing multiple anti-osteoporosis medications for postoperative re-fracture, hip BMD, and function/pain after hip fragility fracture found time- and outcome-specific…
A systematic review and meta-analysis compared multiple drug classes in type 1 diabetes (T1DM) patients for kidney markers and safety; results showed an overall reduction in urine…
A systematic review found limited and inconsistent evidence on the effects of SGLT2 inhibitors on bone health in CKD patients, with particularly scarce data in advanced CKD populations [1].
A systematic review compared CKD cases with and without CUA and identified multiple clinical and laboratory factors associated with CUA occurrence, but mechanisms and causality remain not…
A single-arm meta-analysis of diabetic patients with biopsy-proven MASH found SGLT2 inhibitors were associated with improvements in multiple liver, metabolic, and histologic markers versus…
A systematic review including two randomized controlled trials found teriparatide to be associated with improvements in bone mineral density, but the evidence and safety data remain…
This summary is based on a network meta-analysis that included 27 randomized controlled trials (total n=965) comparing two sequences in concurrent training—aerobic→resistance (CART) versus…
This systematic review and meta-analysis summarizes 36 studies reporting factors associated with the probability of remission of type 2 diabetes (T2DM), noting that the direction of the BMI…
A UK multicenter double-blind feasibility trial compared Anakinra with intramuscular methylprednisolone for gout flares in people with chronic kidney disease; the study reported recruitment…
This summary compiles the 2026 joint guidance, describing when to consider resmetirom or semaglutide, how to choose between them, and key monitoring points in non-cirrhotic MASH with…
A systematic review and meta-analysis of randomized trials found that GLP-1 receptor agonists in CKD patients, predominantly with type 2 diabetes, were associated with lower rates of major…
本系統性回顧與統合分析檢視既存慢性腎臟病（CKD）患者在接受尿路鏡/腎內逆行手術後的腎功能變化，結果顯示整體無顯著惡化，但證據等級很低且異質性高，需謹慎解讀。[1]
A French multicenter randomized trial comparing standard therapy ± bortezomib showed no significant efficacy difference, but the combination group had more serious adverse events.[1]
A systematic review and random-effects meta-analysis showed MASLD and higher liver fibrosis risk are significantly associated with atrial fibrillation (AF) recurrence after catheter…
Añadir Beyond CKD a la pantalla de inicio
Ábralo como una app y consulte sin conexión los artículos y herramientas ya visitados.